Molecule Ecosystem, November 2024
Latest Catalyst Projects, Pump Science Updates, DeSci Ecosystem Fund, New IPTs Molecule DAOs, BIO Protocol Launches New BioDAOs, and more!
DeSci has finally captured the crypto mindshare! Following Binance’s investment in BIO Protocol, successful advancement of Pump Science $URO and $RIF trials, and increased visibility from Vitalik and CZ’s Devcon appearances, DeSci has emerged as a main crypto narrative.
The Molecule ecosystem alone has seen remarkable growth, with over $2M funding six new projects on Catalyst and hundreds of millions flowing through Pump Science.
Here's what's happening:
Catalyst Sees Six More Projects Funded
Six new projects have launched and successfully met their fundraising goals on Catalyst.
Percepta (Cerebrum DAO): 127.7 ETH Raised
Nisi Ovaria (AthenaDAO): 82.4 ETH Raised
See the Difference (Dr. Gian de Nicola from Kings College London): 92.1 ETH Raised
Prima Donna (Dr. Hannele Ruohola-Baker from the University of Washington): 68.3 ETH Raised
Ab4AD (Dr. Daniel Bar from Tel Aviv University): 78.8 ETH Raised
The IPTs for both Ab4AD and Percepta are now available to claim! Follow Catalyst on X and join the Telegram for project news and the latest updates.
To claim your tokens:
Navigate to project
Connect wallet
View Allocation + Sign IPT agreement
Claim your IPTs!
Add token to wallet
We have more projects launching on Catalyst soon! View all the funded, active, and upcoming projects here.
Pump Science Updates
November marked significant progress for Pump Science, as both Urolithin A and Rifampicin advanced from Wormbot to Flybox! Stay tuned for the upcoming Mouse Olympics, coming 2025.
Other fun tidbits:
VitaDAO Compounds Launching on Pump Science: Early 2025 will see VitaDAO's Longevity Prize compounds developed into supplements directly on the platform.
BIO Protocol Partnership: BioDAOs in the BIO Network will use Pump Science for transparent, community-driven IP testing.
Molecule Buys $200k worth of $URO and $RIF: Molecule has invested $100k each in $URO and $RIF tokens to strengthen alignment with community success.
New Partnerships and Product Updates are Coming Soon!
Expanding DeSci on Solana
Building on our support for BIO's vision, Molecule is allocating 166M BIO (half of our allocation) to establish a DeSci Ecosystem Fund. This initiative will accelerate bringing scientific IP onchain by supporting community-driven research and funding proposals. You can read more here.
AthenaDAO Launches $FACC IPT
AthenaDAO has launched its first IP-Token from the “Understanding the role of the cGAS-STING pathway and senescence in ovarian aging” IPT-NFT by Dr. Mario D. Cordero at Pablo de Olavide University.
In August, 2023, AthenaDAO announced their commitment to combat ovarian aging by dedicating $120,000 to Dr. Mario Cordero’s research. Since then, the project has shown promising result, and the community has voted to tokenize the Cordero IP-NFT.
Help AthenaDAO F/ACC and tackle ovarian aging by contributing to the $FACC token auction on Molecule! The auction closes Friday, December 13th, 2024 at 9 AM PT / 12 PM ET / 6 PM CET.
Note: You must hold $ATH tokens to participate in the auction.
BIO Protocol Launches New BioDAOs
A new cohort of BioDAOs have gone through the BIO Incubator and are live. BIO Protocol launched the BIO Incubator as a program designed for biotech luminaries who understand the power of community and want to build web3-native organizations that accelerate science.
Here is a quick overview of the latest BioDAOs:
Quantum Bio DAO
Quantum Biology DAO, co-founded by quantum biology expert Dr. Clarice Aiello and Leverage founder Geoff Anders, is developing quantum microscopes to study how weak magnetic fields influence cellular processes, while building an open IP collective to advance quantum biology applications in health and drug discovery.
Long COVID Labs
Long COVID Labs, founded by Stanford/Harvard-MIT neuroscientist and Long COVID survivor Rohan Dixit, is building an open marketplace to accelerate treatments for 100M+ Long COVID patients, with their first treatment launching November 2024 to address this $1T global health crisis.
Curetopia
Curetopia, led by Ethan Perlstein, is targeting the $1T rare disease market by empowering patients and families to participate in research and drug development, specifically focusing on smaller-market diseases ($200M average) that traditional pharma avoids. Ethan has led multiple research initiatives, including advancing a rare disease treatment to Stage 3 clinical trials for just $5M.
BIO Genesis Raises Over $58M for DeSci
The BIO Genesis auction has ended, raising over $58M to bring more science onchain. The BIO Genesis was the BIO token’s fair launch - designed to distribute ownership of BIO to the public and bootstrap the network prior to the protocol going live and the BIO token becoming transferrable.
These tokens make-up the BIO Treasury, a diverse bucket BioDAO assets and tokenized IP, which will accrue stakes in future BioDAOs as they're voted into the network.
You can read more here.
DeSci Content Roundup
Thanks for Reading!
If you enjoyed this read, subscribe to our newsletter and stay updated as the ecosystem grows. Please reach out to us with any questions or ideas, visit our website, or join our Discord to interact directly with our team. We’re really looking forward to joining forces with our community to create a world where patients directly fund researchers developing the next therapeutic breakthrough they need and building an open, inclusive, and collaborative ecosystem.
Disclaimer: The views and opinions expressed in this newsletter are solely those of the individual authors and contributors. This content is provided for informational purposes only and should not be interpreted as investment advice, endorsement, or recommendation. Readers are advised to conduct their own research and consult with a professional advisor before making any investment decisions.